RESEARCH INTRODUCTION

研究紹介

TOP 研究紹介研究グループ紹介免疫グループ

免疫グループ

研究グループ紹介

免疫グループ

最近5年間の当グループ関連の研究業績は最下段にあります

-学生・研修医教育-

従来の授業・実習カリキュラムに加え、医学部4年生の希望者を対象に、2013年より膠原病セミナー (AOT: Autoimmune disease Overview Training) を8月末に開催しております。リウマチ膠原病学に興味を持って頂くきっかけになれば幸いです。

実習中に担当した症例の学会や英語論文での発表も積極的に支援しています。
2018年4月より、当科をローテート中の研修医を中心とした膠原病レジデントカンファレンスを開始しています。全身を幅広く診ることに始まり、標準治療だけでなく最新の知見や患者さんの背景も踏まえての治療選択といった実臨床を学ぶとともに、プレゼンテーション能力を鍛える機会になればと考えています。

【最近5年間の学生・研修医の業績】は最下段にあります

-基礎研究-

膠原病・リウマチ性疾患の免疫異常と組織障害を分子レベルで解明し,効率的な治療の開発に貢献したいと考え、現在大学院生と留学生を中心に、精力的に研究を行っています。

  1. 関節リウマチの関節破壊の分子機構の解明、関節滑膜病変部におけるサイトカインの発現異常、病因・病態との関連およびその誘導機構の解明

    様々な因子に着目し、関節リウマチにおける炎症性骨破壊の機序を探索しています。

    破骨細胞(骨を壊す)

    脂肪細胞

  2. SLEモデル動物、ノックアウトマウスを用いた自己免疫現象の成立・進展機構解明

    ノックアウトマウスを作成し、SLE発症に関与する因子の生体内での機能を検討しています。

  3. SLE、血管炎などの膠原病の病態形成おけるmiRNAを介したエピジェネティクス的制御機構の解析

    miRNAを網羅的に探索し、膠原病発症における機能を検討しています。

    (Katsuyama E, et al. J Immunol 2017)

【最近5年間の基礎研究業績】は最下段にあります

-臨床研究-

リウマチ・膠原病を対象として、主に観察研究を中心に展開しています。

  1. 抗好中球細胞質抗体(ANCA)関連血管炎の多施設共同前向きコホート研究(RemIT-JAV, RemIT-JAV-RPGN,など)

    公的研究班で行っているANCA関連血管炎を対象とした多施設共同研究です。本研究データを用いて、これまで当科からも多くの研究成果を報告しています。

    Sada KE et al. Arthritis Res Ther. 2015

  2. 関節リウマチに関する観察研究(OKRA1~3)

    岡山大学病院に通院中の関節リウマチ患者さんを対象とした観察研究です。

  3. 全身性エリテマトーデスの多施設レジストリー構築(LUNA2)(昭和大学、長崎大学、横浜市立大学、聖隷浜松病院)

    全国5施設に通院中の全身性エリテマトーデス患者さんを対象として、多種のリサーチクエスチョンに対応可能なレジストリーを構築しています。

  4. 全身性エリテマトーデス診療の質の検討

    多施設共同での全身性エリテマトーデス診療におけるレセプトデータを活用した診療の質指標の開発・検証研究に参加しています。

  5. 皮膚筋炎・多発性筋炎の自己抗体と症状に関する研究

    筋炎特異的な自己抗体と臨床症状との関連を、クラスター解析を用いて分類し、アウトカムとの関連を調べる単施設での歴史的コホート研究です。

  6. 全身性エリテマトーデスの低補体と再燃に関する研究

    全身性エリテマトーデス診療において再燃抑制のために治療介入が必要となる低補体血症を検討するために行った単施設での歴史的コホート研究です。

  7. ループス腎炎の臨床的・組織学的指標に関する研究

    ループス腎炎患者の組織学的活動性病変や慢性病変を予測する臨床的指標を探索するための単施設での歴史的コホート研究です。

  8. リウマチ性多発筋痛症の新たな分類の試み(PRIMERA)

    多様な臨床病態を呈するリウマチ性多発筋痛症患者を、クラスター分類を用いて臨床的な亜分類をすることを試みた単施設での歴史的コホート研究です。

  9. 膠原病患者における糖尿病等の合併症に関する研究(DIMERD)

    膠原病患者における様々な代謝性合併症を網羅的に検討し、合併症の予防や治療への架け橋となるための単施設前向きコホート研究です。

【最近5年間の臨床研究業績】は最下段にあります

-診療-

年間約280名の入院診療、約1600名の外来診療を行っています。主な対象疾患は下記のとおりです。
関節リウマチ
全身性エリテマトーデス
ANCA関連血管炎
皮膚筋炎・多発性筋炎
高安動脈炎
巨細胞性動脈炎
全身性強皮症(全身性硬化症)
混合性結合組織病

【最近5年間の学生・研修医の業績】

Segoe S, Sada KE, Hayashi K, Yamamura Y, Morishita M, Watanabe H, Matsumoto Y, Wada J.

Antineutrophil cytoplasmic antibody-positive familial Mediterranean fever and hyperthyroidism: A case report. Medicine (Baltimore). 97(51):e13805, 2018

Refractory neuromyelitis optica spectrum disorder in systemic lupus erythematosus successfully treated with rituximab.

Shidahara K, Hayashi K, Sada KE, Hiramatsu S, Morishita M, Watanabe H, Matsumoto Y, Kawabata T, Wada J.

Lupus. 2018 Jan 1:961203318760994. doi: 10.1177/0961203318760994. PMID: 29498304

Development of Hypertrophic Pachymeningitis in a Patient With Antineutrophil Cytoplasmic Antibody-Negative Eosinophilic Granulomatosis With Polyangiitis.

Nakano Y, Miyawaki Y, Sada KE, Yamamura Y, Kano Y, Hayashi K, Watanabe H, Matsumoto Y, Kawabata T, Wada J.

J Clin Rheumatol. 2018 Feb 27. doi: 10.1097/RHU.0000000000000694. PMID: 29485545

Cavernous Transformation and Granulomatous Epididymis in Behçet Disease.

Motokura Y, Watanabe H, Yamamura Y, Kano Y, Matsumoto Y, Kawabata T, Sada KE, Wada J.

J Clin Rheumatol. 2018 Feb 22. doi: 10.1097/RHU.0000000000000723. PMID: 29470260

Occurrence of Dermatomyositis Immediately after Mastectomy Subsequent to Severe Chemotherapeutic Drug Eruption.

Otsuka Y, Watanabe H, Kano Y, Tatebe N, Sunahori-Watanabe K, Kawabata T, Sada KE, Wada J.

Intern Med. 2017;56(24):3379-3383. doi: 10.2169/internalmedicine.9194-17. PMID: 29249766

The Successful Treatment of Refractory Polyarteritis Nodosa Using Infliximab.

Matsuo S, Hayashi K, Morimoto E, Kato A, Sada KE, Watanabe H, Takano-Narazaki M, Sunahori-Watanabe K, Kawabata T, Wada J.

Intern Med. 2017;56(11):1435-1438. doi: 10.2169/internalmedicine.56.8235.PMID: 28566612

【最近5年間のグループ関連研究業績】

Certolizumab Pegol is Effective for Granulocyte Colony-Stimulating Factor-Mediated Disease Exacerbation in Rheumatoid Arthritis.
Morimoto E, Matsumoto Y, Asada R, Asano Y, Hayashi K, Hiramatsu-Asano S, Yamamura Y, Morishita M, Ohashi K, Watanabe H, Narazaki M, Kawabata T, Sada KE, Wada J.
Annals of Case Reports. in press

Clinical and Pathogenic features of the Cranial Developmental Disorder Cherubism.
Matsumoto Y, Rottapel R. Encyclopedia of Medical Immunology: Immunodeficiency Diseases. in press

Refractory Takayasu arteritis responding to the oral janus kinase inhibitor, tofacitinib.
Yamamura Y, Matsumoto Y, Asano Y, Katayama Y, Hayashi K, Ohashi K, Morishita M, Watanabe H, Narazaki M, Sada KE, Wada J.
Rheumatology Advances in Practice. in press

Rationale of concomitant cyclophosphamide for remission-induction in patients with antineutrophil cytoplasmic antibody-associated vasculitis: A propensity score-matched analysis of two nationwide prospective cohort studies.
Watanabe H, Sada KE, Matsumoto Y, Harigai M, Amano K, Fujimoto S, Dobashi H, Yuzawa Y, Yamagata K, Muso E, Arimura Y, Makino H.
Modern Rheumatology. in press

Thrombocytosis as a prognostic factor in polymyalgia rheumatica: characteristics determined from cluster analysis.
Hayashi K, Ohashi K, Watanabe H, Sada KE, Shidahara K, Asano Y, Asano SH, Yamamura Y, Miyawaki Y, Morishita M, Matsumoto Y, Kawabata T, Wada J.
Therapeutic Advances in Musculoskeletal Disease. in press

Simultaneous development of IgA vasculitis and eosinophilic granulomatosis with polyangiitis.
Asano Y, Matsumoto Y, Miyazaki T, Ishizu A, Morizane S, Hayashi K, Yamamura Y, Hiramatsu S, Miyawaki Y, Morishita M, Ohashi K, Watanabe H, Watanabe KS, Kawabata T, Sada KE, Makino H, Wada J.
Modern Rheumatology Case Reports. 4(1):63-69, 2019

Risk factors for cytomegalovirus infection in patients with antineutrophil cytoplasmic antibody-associated vasculitis.
Morishita M, Sada KE, Matsumoto Y, Hayashi K, Asano Y, Hiramatsu Asano S, Ohashi K, Miyawaki Y, Katsuyama E, Watanabe H, Kawabata T, Wada J.
PLoS One. 14(7):e0218705, 2019

Regulation of Cathepsin E gene expression by the transcription factor Kaiso in MRL/lpr mice derived CD4+ T cells.
Hiramatsu S, Watanabe KS, Zeggar S, Asano Y, Miyawaki Y, Yamamura Y, Katsuyama E, Katsuyama T, Watanabe H, Takano-Narazaki M, Matsumoto Y, Kawabata T, Sada KE, Wada J.
Scientific Reports. 9(1):3054, 2019

Lymphoproliferative disease in a patient with Takayasu arteritis and ulcerative colitis.
Asano Y, Sada KE, Hayashi K, Yamamura Y, Hiramatsu S, Ohashi K, Miyawaki Y, Morishita M, Watanabe H, Matsumoto Y, Kawabata T, Tanaka N, Hiraoka S, Wada J.
Modern Rheumatology Case Reports. 3(1):34-37, 2019

Cluster Analysis Using Anti-Aminoacyl-tRNA Synthetases and SS-A/Ro52 antibodies in Patients With Polymyositis/Dermatomyositis.
Ohashi K, Sada KE, Nakai Y, Matsushima S, Asano Y, Hayashi K, Yamamura Y, Hiramatsu S, Miyawaki Y, Morishita M, Katsuyama T, Katsuyama E, Watanabe H, Tatebe N, Narazaki M, Matsumoto Y, Sunahori Watanabe K, Kawabata T, Wada J.
JCR: Journal of Clinical Rheumatology. 25(6):246-251, 2019

Association between reappearance of myeloperoxidase-antineutrophil cytoplasmic antibody and relapse in antineutrophil cytoplasmic antibody-associated vasculitis: Subgroup analysis of nationwide prospective cohort studies. Watanabe H, Sada KE, Matsumoto Y, Harigai M, Amano K, Dobashi H, Fujimoto S, Usui J, Yamagata K, Atsumi T, Banno S, Sugihara T, Arimura Y, Matsuo S, Makino H. Arthritis & Rheumatology. 70(10):1626-1633, 2018

Miyawaki Y, Sada KE, Asano Y, Hayashi K, Yamamura Y, Hiramatsu S, Ohashi K, Morishita M, Watanabe H, Matsumoto Y, Sunahori-Watanabe K, Kawabata T, Wada J.
An open-label pilot study on preventing glucocorticoid-induced diabetes mellitus with linagliptin.
Journal of Medical Case Reports. 12(1):288, 2018

Lgals9 deficiency attenuates nephritis and arthritis in pristane-induced lupus model of BALB/c mice.
Zeggar S, Watanabe KS, Teshigawara S, Hiramatsu S, Katsuyama T, Katsuyama E, Watanabe H, Matsumoto Y, Kawabata T, Sada KE, Niki T, Hirashima M, Wada J.
Arthritis Rheumatol. 2018 Feb 26. doi: 10.1002/art.40467. PMID: 29481735

Risk Factors for Relapse of Antineutrophil Cytoplasmic Antibody-associated Vasculitis in Japan: A Nationwide, Prospective Cohort Study.
Hara A, Wada T, Sada KE, Amano K, Dobashi H, Harigai M, Takasaki Y, Yamada H, Hasegawa H, Hayashi T, Fujimoto S, Muso E, Kawakami T, Homma S, Yoshida M, Hirahashi J, Ogawa N, Ito S, Makino H, Arimura Y; Research Committee on Intractable Vasculitides, and the Strategic Study Group to Establish the Evidence for Intractable Vasculitis Guideline.
J Rheumatol. 2018 Apr;45(4):521-528. doi: 10.3899/jrheum.170508. PMID: 29419469

Potential Benefit Associated With Delaying Initiation of Hemodialysis in a Japanese Cohort.
Higuchi S, Nakaya I, Yoshikawa K, Chikamatsu Y, Sada KE, Yamamoto S, Takahashi S, Sasaki H, Soma J.
Kidney Int Rep. 2017 Feb 10;2(4):594-602. doi: 10.1016/j.ekir.2017.01.015.PMID: 29318218

Association of ETS1 polymorphism with granulomatosis with polyangiitis and proteinase 3-anti-neutrophil cytoplasmic antibody positive vasculitis in a Japanese population.
Kawasaki A, Yamashita K, Hirano F, Sada KE, Tsukui D, Kondo Y, Kimura Y, Asako K, Kobayashi S, Yamada H, Furukawa H, Nagasaka K, Sugihara T, Yamagata K, Sumida T, Tohma S, Kono H, Ozaki S, Matsuo S, Hashimoto H, Makino H, Arimura Y, Harigai M, Tsuchiya N.
J Hum Genet. 2018 Jan;63(1):55-62. doi: 10.1038/s10038-017-0362-2. PMID: 29167552

Alternative to Rituximab Therapy for a Patient with Ankylosing Spondylitis Who Was Unable to Continue Anti-TNF Therapy.
Katsuyama E, Wakabayashi H, Sada KE, Hiramatsu S, Miyawaki Y, Morishita M, Ohashi K, Watanabe H, Katsuyama T, Zeggar S, Narazaki M, Tatebe N, Sunahori-Watanabe K, Kawabata T, Wada J.
Acta Med Okayama. 2017 Oct;71(5):445-448. doi: 10.18926/AMO/55444.PMID: 29042704

Targeted proteomics reveals promising biomarkers of disease activity and organ involvement in antineutrophil cytoplasmic antibody-associated vasculitis.
Ishizaki J, Takemori A, Suemori K, Matsumoto T, Akita Y, Sada KE, Yuzawa Y, Amano K, Takasaki Y, Harigai M, Arimura Y, Makino H, Yasukawa M, Takemori N, Hasegawa H; Research Committee of Intractable Vasculitis Syndrome and the Research Committee of Intractable Renal Disease of the Ministry of Health, Labour and Welfare of Japan.
Arthritis Res Ther. 2017 Sep 29;19(1):218. doi: 10.1186/s13075-017-1429-3.PMID: 28962592

Central Diabetes Insipidus in Refractory Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
Ohashi K, Morishita M, Watanabe H, Sada KE, Katsuyama T, Miyawaki Y, Katsuyama E, Narazaki M, Tatebe N, Watanabe K, Kawabata T, Wada J.
Intern Med. 2017 Nov 1;56(21):2943-2948. doi: 10.2169/internalmedicine.8683-16. PMID: 28943556

Shorter dialysis session length was not associated with lower mental health and physical functioning in elderly hemodialysis patients: Results from the Japan Dialysis Outcome and Practice Patterns Study (J-DOPPS).
Kitagawa M, Sada KE, Hinamoto N, Kimachi M, Yamamoto Y, Onishi Y, Fukuhara S.
PLoS One. 2017 Sep 6;12(9):e0184019. doi: 10.1371/journal.pone.0184019. PMID: 28877202

Azathioprine Intolerance in Japanese Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
Morishita M, Watanabe H, Yan M, Zeggar S, Hiramatsu S, Ohashi K, Miyawaki Y, Katsuyama E, Katsuyama T, Takano Narazaki M, Toyota Tatebe N, Sunahori Watanabe K, Kawabata T, Sada KE, Wada J.
Intern Med. 2017;56(13):1645-1650. doi: 10.2169/internalmedicine.56.8287.PMID: 28674351

Anti-high Mobility Group Box 1 Antibody Ameliorates Albuminuria in MRL/lpr Lupus-Prone Mice.
Watanabe H, Watanabe KS, Liu K, Hiramatsu S, Zeggar S, Katsuyama E, Tatebe N, Akahoshi A, Takenaka F, Hanada T, Akehi M, Sasaki T, Sada KE, Matsuura E, Nishibori M, Wada J.
Mol Ther Methods Clin Dev. 2017 May 25;6:31-39. doi: 10.1016/j.omtm.2017.05.006. PMID: 28649578

Prediction of response to remission induction therapy by gene expression profiling of peripheral blood in Japanese patients with microscopic polyangiitis.
Ishizu A, Tomaru U, Masuda S, Sada KE, Amano K, Harigai M, Kawaguchi Y, Arimura Y, Yamagata K, Ozaki S, Dobashi H, Homma S, Okada Y, Sugiyama H, Usui J, Tsuboi N, Matsuo S, Makino H; Research Committee of the Intractable Vasculitis Syndrome and the Research Committee of the Intractable Renal Disease of the Ministry of Health, Labour, and Welfare of Japan.
Arthritis Res Ther. 2017 May 31;19(1):117. doi: 10.1186/s13075-017-1328-7.PMID: 28569178

A retrospective observational study of glucocorticoid-induced diabetes mellitus with IgA nephropathy treated with tonsillectomy plus methylprednisolone pulse therapy.
Miyawaki Y, Katsuyama T, Sada KE, Hiramatsu S, Ohashi K, Morishita M, Katsuyama E, Watanabe H, Takano-Narazaki M, Toyota-Tatebe N, Sunahori-Watanabe K, Kawabata T, Inoue T, Kinomura M, Sugiyama H, Wada J.
PLoS One. 2017 May 31;12(5):e0178018. doi: 10.1371/journal.pone.0178018.PMID: 28562629

Development of intracerebral hemorrhage in the short-term clinical course of a patient with microscopic polyangiitis without neurological symptoms at diagnosis: an autopsy case.
Miyawaki Y, Katsuyama T, Sada KE, Taniguchi K, Kakio Y, Wada J.
CEN Case Rep. 2016 Nov;5(2):173-178. doi: 10.1007/s13730-016-0219-0. PMID: 28508972

Downregulation of miR-200a-3p, Targeting CtBP2 Complex, Is Involved in the Hypoproduction of IL-2 in Systemic Lupus Erythematosus-Derived T Cells.
Katsuyama E, Yan M, Watanabe KS, Matsushima S, Yamamura Y, Hiramatsu S, Ohashi K, Watanabe H, Katsuyama T, Zeggar S, Yoshida N, Moulton VR, Tsokos GC, Sada KE, Wada J.
J Immunol. 2017 Jun 1;198(11):4268-4276. doi: 10.4049/jimmunol.1601705.PMID: 28438897

Prognostic factors of methotrexate-associated lymphoproliferative disorders associated with rheumatoid arthritis and plausible application of biological agents.
Katsuyama T, Sada KE, Yan M, Zeggar S, Hiramatsu S, Miyawaki Y, Ohashi K, Morishita M, Watanabe H, Katsuyama E, Takano-Narazaki M, Toyota-Tatebe N, Sunahori-Watanabe K, Kawabata T, Miyake K, Kiguchi T, Wada J.
Mod Rheumatol. 2017 Sep;27(5):773-777. doi: 10.1080/14397595.2016.1259714. PMID: 27846761

Clinical characteristics of and risk factors for serious infection in Japanese patients within six months of remission induction therapy for antineutrophil cytoplasmic antibody-associated vasculitis registered in a nationwide, prospective, inception cohort study.
Watanabe-Imai K, Harigai M, Sada KE, Yamamura M, Fujii T, Dobashi H, Amano K, Ito S, Homma S, Kumagai S, Banno S, Arimura Y, Makino H; Research Committee on Intractable Vasculitides, the Ministry of Health, Labor and Welfare of Japan.
Mod Rheumatol. 2017 Jul;27(4):646-651. doi: 10.1080/14397595.2016.1226468. PMID: 27538706

Protective Role of HLA-DRB1*13:02 against Microscopic Polyangiitis and MPO-ANCA-Positive Vasculitides in a Japanese Population: A Case-Control Study.
Kawasaki A, Hasebe N, Hidaka M, Hirano F, Sada KE, Kobayashi S, Yamada H, Furukawa H, Yamagata K, Sumida T, Miyasaka N, Tohma S, Ozaki S, Matsuo S, Hashimoto H, Makino H, Arimura Y, Harigai M, Tsuchiya N.
PLoS One. 2016 May 11;11(5):e0154393. doi: 10.1371/journal.pone.0154393. PMID: 27166610

Development of quality indicators for care of chronic kidney disease in the primary care setting using electronic health data: a RAND-modified Delphi method.
Fukuma S, Shimizu S, Niihata K, Sada KE, Yanagita M, Hatta T, Nangaku M, Katafuchi R, Fujita Y, Koizumi J, Koizumi S, Kimura K, Fukuhara S, Shibagaki Y.
Clin Exp Nephrol. 2017 Apr;21(2):247-256. doi: 10.1007/s10157-016-1274-8.PMID: 27145768

Bilateral Abducens Nerve Palsy due to Idiopathic Intracranial Hypertension as an Initial Manifestation of Systemic Lupus Erythematosus.
Katsuyama E, Sada KE, Tatebe N, Watanabe H, Katsuyama T, Narazaki M, Sugiyama K, Watanabe KS, Wakabayashi H, Kawabata T, Wada J, Makino H.
Intern Med. 2016;55(8):991-4. doi: 10.2169/internalmedicine.55.5990. PMID: 27086818

Comparison of severity classification in Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study.
Sada KE, Harigai M, Amano K, Atsumi T, Fujimoto S, Yuzawa Y, Takasaki Y, Banno S, Sugihara T, Kobayashi M, Usui J, Yamagata K, Homma S, Dobashi H, Tsuboi N, Ishizu A, Sugiyama H, Okada Y, Arimura Y, Matsuo S, Makino H; for Research Committee of Intractable Vasculitis Syndrome and Research Committee of Intractable Renal Disease of the Ministry of Health, Labour, and Welfare of Japan.
Mod Rheumatol. 2016 Sep;26(5):730-7. doi: 10.3109/14397595.2016.1140274. PMID: 26873424

Different responses to treatment across classified diseases and severities in Japanese patients with microscopic polyangiitis and granulomatosis with polyangiitis: a nationwide prospective inception cohort study.
Sada KE, Yamamura M, Harigai M, Fujii T, Takasaki Y, Amano K, Fujimoto S, Muso E, Murakawa Y, Arimura Y, Makino H; Research Committee on Intractable Vasculitides, the Ministry of Health, Labour and Welfare of Japan.
Arthritis Res Ther. 2015 Nov 2;17:305. doi: 10.1186/s13075-015-0815-y.PMID: 26525413

Regulatory effects of fibroblast growth factor-8 and tumor necrosis factor-α on osteoblast marker expression induced by bone morphogenetic protein-2.
Katsuyama T, Otsuka F, Terasaka T, Inagaki K, Takano-Narazaki M, Matsumoto Y, Sada KE, Makino H.
Peptides. 2015 Nov;73:88-94. doi: 10.1016/j.peptides.2015.09.007. PMID: 26409788

The efficacy of add-on tacrolimus for minor flare in patients with systemic lupus erythematosus: a retrospective study.
Watanabe H, Yamanaka R, Sada KE, Zeggar S, Katsuyama E, Katsuyama T, Narazaki MT, Tatebe NT, Sugiyama K, Watanabe KS, Wakabayashi H, Kawabata T, Wada J, Makino H.
Lupus. 2016 Jan;25(1):54-60. doi: 10.1177/0961203315600538. PMID: 26296361

A national survey on current use of mycophenolate mofetil for childhood-onset systemic lupus erythematosus in Japan.
Hara R, Miyazawa H, Nishimura K, Momoi T, Nozawa T, Kikuchi M, Sakurai N, Kizawa T, Shimamura S, Yasuda S, Hiromura K, Sada KE, Kawaguchi Y, Tamura N, Takei S, Takasaki Y, Atsumi T, Mori M.
Mod Rheumatol. 2015;25(6):858-64. doi: 10.3109/14397595.2015.1077555.PMID: 26215483

Risk Score to Predict 1-Year Mortality after Haemodialysis Initiation in Patients with Stage 5 Chronic Kidney Disease under Predialysis Nephrology Care.
Doi T, Yamamoto S, Morinaga T, Sada KE, Kurita N, Onishi Y.
PLoS One. 2015 Jun 9;10(6):e0129180. doi: 10.1371/journal.pone.0129180. PMID: 26057129

Mentoring the next generation of physician-scientists in Japan: a cross-sectional survey of mentees in six academic medical centers.
Sakushima K, Mishina H, Fukuhara S, Sada K, Koizumi J, Sugioka T, Kobayashi N, Nishimura M, Mori J, Makino H, Feldman MD.
BMC Med Educ. 2015 Mar 19;15:54. doi: 10.1186/s12909-015-0333-2.PMID: 25890341

Surveillance for the use of mycophenolate mofetil for adult patients with lupus nephritis in Japan.
Yasuda S, Atsumi T, Shimamura S, Ono K, Hiromura K, Sada K, Mori M, Takei S, Kawaguchi Y, Tamura N, Takasaki Y.
Mod Rheumatol. 2015;25(6):854-7. doi: 10.3109/14397595.2015.1031444.PMID: 25800636

Risk factors for the development of glucocorticoid-induced diabetes mellitus.
Katsuyama T, Sada KE, Namba S, Watanabe H, Katsuyama E, Yamanari T, Wada J, Makino H.
Diabetes Res Clin Pract. 2015 May;108(2):273-9. doi: 10.1016/j.diabres.2015.02.010.PMID: 25765669

Pulmonary involvements of anti-neutrophil cytoplasmic autoantibody-associated renal vasculitis in Japan.
Hirayama K, Kobayashi M, Usui J, Arimura Y, Sugiyama H, Nitta K, Muso E, Wada T, Matsuo S, Yamagata K; Japanese RPGN Study Group of Progressive Renal Disease.
Nephrol Dial Transplant. 2015 Apr;30 Suppl 1:i83-93. doi: 10.1093/ndt/gfu385. PMID: 25613541

Issues associated with the Ministry of Health, Labour and Welfare diagnostic criteria for antineutrophil cytoplasmic antibody-associated vasculitides: Reclassification of patients in the prospective cohort study of Remission Induction Therapy in Japanese patients with ANCA-associated vasculitides according to the MHLW criteria.
Sada KE, Yamamura M, Harigai M, Fujii T, Arimura Y, Makino H; Research Committee on Intractable Vasculitides, the Ministry of Health, Labour and Welfare of Japan.
Mod Rheumatol. 2015 Jul;25(4):657-9. doi: 10.3109/14397595.2014.982270.PMID: 25496407

(責任者:松本佳則)